Peter S. Roddy
Geen lopende functies
Loopbaan van Peter S. Roddy
Eerdere bekende functies van Peter S. Roddy
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CYTOKINETICS, INCORPORATED | Comptroller/Controller/Auditor | 03-04-2017 | 15-05-2019 |
| CASSAVA SCIENCES, INC. | Financieel Directeur/CFO | 01-11-2002 | 09-03-2017 |
| ASPIRA WOMEN'S HEALTH INC. | Directeur/Bestuurslid | 01-02-2010 | 16-06-2016 |
| Independent Dir/Board Member | 01-02-2010 | 16-06-2016 | |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Financieel Directeur/CFO | 01-01-2002 | 01-01-2012 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Directeur/Bestuurslid | 22-10-2010 | - |
Opleiding van Peter S. Roddy
| University of California, Berkeley | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director of Finance/CFO | 2 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| CASSAVA SCIENCES, INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
- Beurs
- Insiders
- Peter S. Roddy
- Ervaring
